- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01477372
Effect of Physical Exercise Program During Pregnancy on Excessive Weight Gain and Its Consequences
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
BACKROUND: Pregnancy and delivery can condition significantly women's health. In particular, an excessive gain of weight during pregnancy constitutes a risk factor which may lead to (i) different alterations during pregnancy such as gestational diabetes or hypertension, (ii) foetus health problems (macrosomia), (iii) delivery complications (dystocia, prolonged labour and increased number of caesareans) and (iv) future health disorders for the woman (overweight, obesity and cardiovascular alterations). Furthermore, during pregnancy pelvic floor health problems, such as urinary incontinence (IU) may arise or worsen.
OBJECTIVES: The main aim of this study was to assess the effectiveness of a moderate physical exercise program called Blooming Exercise Program (BEP) developed during pregnancy in order to control excessive maternal weight gain and its consequences. Additionally, other objectives of the study were to analyse the influence of BEP on urinary incontinence, on the other pregnancy outcomes (maternal and foetal) and on the perception of the pregnant's health.
DESIGN: A randomized, controlled trial called has been conducted. 300 healthy pregnant women were recruited and divided into an intervention group (IG, n=100) and a control group (CG, n=200). The IG participated in BEP as from week 10-12 of gestation (at least 56 sessions through 22 weeks. 3 sessions per week). The CG did not participate in any supervised program addressed to pregnant women but received regular health care. Pregnancy outcomes regarding the mother and the new born, urinary incontinence and women's habits data were obtained and registered through initial interviews, medical records and two specific questionnaires on health and urinary incontinency (ICIQ-SF and King's).
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Madrid
-
Fuenlabrada, Madrid, Spania, 28942
- Universitarian Hospital of Fuenlabrada
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Healthy pregnant women
- Delivering in "Hospital Universitario de Fuenlabrada"
- At week 10-14 of gestation
- Able to attend 3 sessions per week until the end of the pregnancy
Exclusion Criteria:
- Contraindications appointed by ACOG
- Less than 56 sessions
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Exercise group
Supervised exercise program
|
Intervention group participated in Blooming Exercise Program as from week 10-12 of gestation.
At least 56 sessions through 22 weeks.
3 sessions per week
|
|
Ingen inngripen: Control
Sedentary pregnant woman
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Maternal weight gain
Tidsramme: week 36-38 of gestation
|
Maternal weight gain and proportion of participants exceeding weight gain above IOM (2009) recommendations
|
week 36-38 of gestation
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Excessive weight gain related risks (gestational diabetes, macrosomia, type of delivery)
Tidsramme: week 36-38 of gestation
|
week 36-38 of gestation
|
|
Urinary incontinence
Tidsramme: week 36-38 of gestation
|
week 36-38 of gestation
|
|
Other pregnancy outcomes (maternal and foetal)
Tidsramme: week 36-38 of gestation
|
week 36-38 of gestation
|
Samarbeidspartnere og etterforskere
Etterforskere
- Studieleder: Ruben O Barakat, PhD, Universidad Politécnica de Madrid.
- Hovedetterforsker: Mireia Peláez, PhD, Universidad Politécnica de Madrid.
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 240/09
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Svangerskap
-
King's College Hospital NHS TrustEuropean Association for the Study of the LiverRekrutteringSkrumplever, lever | HELLP syndrom | Intrahepatisk kolestase ved graviditet | Graviditetssykdom | AFLP - Acute Fatty Liver of PregnancyStorbritannia
Kliniske studier på Supervised exercise program
-
Uludag UniversityTilbaketrukketKneartroseTyrkia (Türkiye)
-
Ahram Canadian UniversityRekrutteringCervikal smerte | LivmorhalsenEgypt
-
Hull University Teaching Hospitals NHS TrustUniversity of HullFullførtIntermitterende Claudication | Femoropoliteal sykdomStorbritannia
-
Dana-Farber Cancer InstituteProstate Cancer FoundationRekrutteringPROSTATAKREFT | Metastatisk prostatakreft | Metastatisk prostatakarsinomForente stater
-
Hunan Normal UniversityShanghai University of SportHar ikke rekruttert ennå
-
Dartmouth-Hitchcock Medical CenterAvsluttetLungekreftForente stater
-
University of Illinois at ChicagoNational Center for Advancing Translational Sciences (NCATS)Har ikke rekruttert ennå
-
University of FloridaFullført
-
Dr. John BartlettSligo General Hospital; Institute of Technology, SligoFullført
-
Marmara UniversityFullførtKontorarbeidere | Arbeidsrelaterte muskel- og skjelettlidelserTyrkia